You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
B
Completed
  • Primary Immunodeficiency Diseases (PID)
  • Recombinant human hyaluronidase + immune globulin intravenous
  • Centennial, Colorado
  • +2 more
2021-04-30
Apr 30, 2021
S
Completed
  • Hereditary Angioedema
  • CINRYZE with rHuPH20
  • Scottsdale, Arizona
  • +3 more
2021-06-16
Jun 16, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
2021-12-02
Dec 2, 2021
B
Completed
  • Primary Immunodeficiency Diseases (PID)
  • Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV)
  • Cypress, California
  • +13 more
2021-04-30
Apr 30, 2021
S
Completed
  • Hereditary Angioedema (HAE)
  • CINRYZE with rHuPH20
  • Birmingham, Alabama
  • +22 more
2021-05-11
May 11, 2021
G
Completed
  • Primary Immunodeficiency
  • Secondary Immune Deficiency
  • HyQvia
  • Paris, France
  • +3 more
2021-07-27
Jul 27, 2021
B
Completed
  • Primary Immunodeficiency Diseases (PID)
  • Immune Globulin Infusion (Human), 10%
  • Recombinant human hyaluronidase
  • Irvine, California
  • +9 more
2021-04-30
Apr 30, 2021
T
Recruiting
  • Healthy Volunteers
  • TAK-881
  • Hialeah, Florida
    Clinical Pharmacology of Miami
2021-11-23
Nov 23, 2021
T
Not yet recruiting
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
  • Multifocal Motor Neuropathy (MMN)
  • (no location specified)
2021-10-10
Oct 10, 2021
M
Withdrawn
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Pegylated Recombinant Human Hyaluronidase PH20
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
2020-03-11
Mar 11, 2020
H
Completed
  • Type 1 Diabetes Mellitus
  • Sham Injection
  • +3 more
  • Chula Vista, California
    Profil Institute for Clinical Research
2019-02-05
Feb 5, 2019
B
Recruiting
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
  • HYQVIA
  • Phoenix, Arizona
  • +34 more
2021-09-08
Sep 8, 2021
H
Completed
  • Type 1 Diabetes Mellitus
  • Chula Vista, California
    Profil Institute for Clinical Research, Inc.
2019-02-04
Feb 4, 2019
B
Completed
  • Primary Immunodeficiency Diseases (PID)
  • SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety)
  • +2 more
  • Cypress, California
  • +10 more
2021-04-30
Apr 30, 2021
H
Completed
  • Type 1 Diabetes Mellitus
  • Rapid Acting insulin with pre-treatment of rHuPH20
  • Sham injection
  • Chula Vista, California
    Profil Institute for Clinical Research
2019-01-30
Jan 30, 2019
C
Unknown status
  • Secondary or Primary Immunodeficiency
  • Data record and questionnaires passation
  • Reims, France
    Damien JOLLY
2019-04-03
Apr 3, 2019
H
Completed
  • Healthy
  • recombinant human hyaluronidase
  • Kalamazoo, Michigan
    Jasper Clinic
2018-09-18
Sep 18, 2018
P
Terminated
  • Pancreatic Ductal Adenocarcinoma
  • Pancreatic Cancer
  • PEGylated Recombinant Human Hyaluronidase (PEGPH20)
  • Avelumab
  • Fuenlabrada, Madrid, Spain
  • +2 more
2019-08-20
Aug 20, 2019